Search Results - Mehrishi, Jitendra N

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency

    Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency by Bakacs, Tibor, Mehrishi, Jitendra N

    Published in Immunobiology (1979)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Electrophoresis of cells and the biological relevance of surface charge

    Electrophoresis of cells and the biological relevance of surface charge by Mehrishi, Jitendra N., Bauer, Johann

    Published in Electrophoresis
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

    Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering? by Bakács, Tibor, Mehrishi, Jitendra N

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Ipilimumab (Yervoy) and the TGN1412 catastrophe

    Ipilimumab (Yervoy) and the TGN1412 catastrophe by Bakacs, Tibor, Mehrishi, Jitendra N, Moss, Ralph W

    Published in Immunobiology (1979)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)

    Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy) by Bakacs, Tibor, Mehrishi, Jitendra N., Szabó, Miklós, Moss, Ralph W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials

    Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials by Mehrishi, Jitendra N, Szabó, Miklós, Bakács, Tibor

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand

    Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand by Bakács, Tibor, Mehrishi, Jitendra N

    Published in BMC cancer
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Surface molecular components of Ehrlich ascites tumour cells

    Surface molecular components of Ehrlich ascites tumour cells by Mehrishi, Jitendra N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: